Showing results (281-290 of 345) with videos related to
Sort By:
Pageof 35
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 30, 2020
Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar VersionDalia Qneibi, Eduardo Ramacciotti, Ariane Scarlatelli Macedo, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 26, 2007
Isolation and characterization of heparin from tuna skinsWalter P Jeske, Meredith K McDonald, Debra A Hoppensteadt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 23, 2022
Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary EmbolismBulent Kantarcioglu, Amir Darki, Fakiha Siddiqui, et al.The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 19, 2007
Preeclampsia is associated with low concentrations of protein ZOffer Erez, Debra Hoppensteadt, Roberto Romero, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 7, 2017
Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With EnoxaparinXinyue Liu, Kalib St Ange, Jawed Fareed, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 15, 2022
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special PopulationsBulent Kantarcioglu, Omer Iqbal, Joseph Lewis, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2002
Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisitedRolandas Gerbutavicius, Jawed Fareed, Harry L Messmore, et al.Journal of the American College of Surgeons|April 24, 2025
Preoperative Biomarkers and Thromboelastometry According to Caprini Venous Thromboembolism Risk Stratification in Bariatric Patients: Are Clinical Risk Assessments Enough?Vanessa N VanDruff, Fakiha Siddiqui, Kristine Kuchta, et al.International Journal of Molecular Sciences|June 26, 2025
Extracellular Vesicles Profile and Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell LymphomaVladimir Otasevic, Charlotte Gran, Natasa Milic, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 3, 2026
Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary EmbolismChongyu Zhang, Bulent Kantarcioglu, Prakasha Kempaiah, et al.Pageof 35